GORE® Aortic Endograft System
GPTKB entity
Statements (62)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:medical_devices
|
| gptkbp:access_site |
femoral artery
|
| gptkbp:benefits |
reduced recovery time
|
| gptkbp:clinical_trial |
ongoing studies
published in medical journals supported by clinical studies various phases conducted |
| gptkbp:clinical_use |
aortic repair
|
| gptkbp:competitors |
other endograft systems
|
| gptkbp:complications |
risk of endoleak
|
| gptkbp:customer_satisfaction |
generally high
|
| gptkbp:design |
modular system
|
| gptkbp:device_approval |
subject to regulatory review
|
| gptkbp:device_innovation |
continuous improvements made
|
| gptkbp:device_longevity |
designed for durability
|
| gptkbp:device_maintenance |
requires regular follow-up
|
| gptkbp:device_performance |
monitored through registries
|
| gptkbp:device_research |
ongoing advancements in technology
|
| gptkbp:effective_date |
FDA approved
|
| gptkbp:eligibility |
determined by vascular specialists
|
| gptkbp:events |
essential for success
at least 5 years regular imaging required |
| gptkbp:features |
low-profile delivery system
|
| gptkbp:first_introduced |
gptkb:2005
|
| gptkbp:funding |
supported by grants
|
| https://www.w3.org/2000/01/rdf-schema#label |
GORE® Aortic Endograft System
|
| gptkbp:is_monitored_by |
critical for long-term success
|
| gptkbp:long_term_outcomes |
generally favorable
|
| gptkbp:manufacturer |
gptkb:W._L._Gore_&_Associates
|
| gptkbp:market_position |
global
|
| gptkbp:material |
e PTFE (expanded polytetrafluoroethylene)
|
| gptkbp:notable_technology |
customizable options available
|
| gptkbp:patient_education |
important for understanding procedure
|
| gptkbp:patient_outcomes_research |
important for future developments
|
| gptkbp:patient_population |
adults
|
| gptkbp:patient_risks |
individualized assessment required
|
| gptkbp:provides_guidance_on |
updated regularly
based on patient assessment recommended by vascular societies |
| gptkbp:recruitment |
based on imaging studies
|
| gptkbp:regulatory_compliance |
gptkb:CE_mark
|
| gptkbp:related_products |
GORE® Excluder® Endoprosthesis
|
| gptkbp:risk_factor |
age and comorbidities
|
| gptkbp:shipping_options |
endovascular procedure
|
| gptkbp:size |
requires accurate measurement
|
| gptkbp:specialties |
minimally invasive
monitoring for complications various techniques employed |
| gptkbp:surgical_outcomes_data |
collected for analysis
|
| gptkbp:surgical_success_rate |
high in experienced hands
|
| gptkbp:surgical_training_programs |
available for surgeons.
|
| gptkbp:training |
available for healthcare providers
surgeon training needed |
| gptkbp:treatment |
improved quality of life
depends on surgeon experience inherent to all surgeries |
| gptkbp:type |
endovascular graft
|
| gptkbp:type_of_insurance |
varies by provider
|
| gptkbp:used_for |
treatment of aortic aneurysms
|
| gptkbp:bfsParent |
gptkb:Gore_Interventional_Devices
|
| gptkbp:bfsLayer |
7
|